[Pharmacological considerations in the economic evaluation of glycopeptides]

Rev Clin Esp. 1997 Sep:197 Suppl 2:68-73.

[Article in Spanish]

Authors

E García-Quetglas¹, B Sádaba, J Honorato

Affiliation

¹ Servicio de Farmacología Clínica, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra.

PMID: 9441326

No abstract available

Publication types

Comparative Study

MeSH terms

Aminoglycosides
Anti-Bacterial Agents / administration & dosage
Anti-Bacterial Agents / economics*
Anti-Bacterial Agents / pharmacology*
Antibiotic Prophylaxis / economics*
Arthritis, Infectious / drug therapy
Bacteremia / drug therapy
Bacterial Infections / drug therapy
Costs and Cost Analysis
Drug Monitoring / economics
Endocarditis, Bacterial / drug therapy
Humans
Osteomyelitis / drug therapy
Staphylococcal Infections / drug therapy
Teicoplanin / administration & dosage
Teicoplanin / economics*
Teicoplanin / pharmacology*
Time Factors
Vancomycin / administration & dosage
Vancomycin / economics*
Vancomycin / pharmacology*

Substances

Aminoglycosides
Anti-Bacterial Agents
Teicoplanin
Vancomycin